Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 05/01/2022 By Sneha ShahMay 3, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 04/24/2022 By Sneha ShahApril 26, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 04/17/2022 By Sneha ShahApril 19, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 02/20/2022 By Sneha ShahFebruary 23, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 01/23/2022 By Sneha ShahJanuary 25, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 01/09/2022 By Sneha ShahJanuary 12, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 01/02/2022 By Sneha ShahJanuary 5, 2022
Leveraged & Inverse Channel Biotech Belonged to the Bears in Second Half of 2021 By Ben HernandezDecember 25, 2021
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 12/05/2021 By Sneha ShahDecember 9, 2021
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 11/28/2021 By Sneha ShahNovember 30, 2021
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 11/14/2021 By Sneha ShahNovember 17, 2021
Leveraged & Inverse Channel This Bearish Biotech ETF Is up 16% in the Past Month By Ben HernandezOctober 12, 2021
Leveraged & Inverse Channel Biotech Rose with the Virus. Now It’s Falling Behind By Ben HernandezMarch 19, 2021
Leveraged & Inverse Channel Post-Vaccine Distribution, Mergers Will Dominate Biotech Industry ETFs By Ben HernandezNovember 24, 2020
Leveraged & Inverse Channel Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019